UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$422M |
| 2 |
iShares US Treasury Bond ETF
GOVT
|
+$342M |
| 3 |
Mondelez International
MDLZ
|
+$328M |
| 4 |
SHPG
Shire pic
SHPG
|
+$323M |
| 5 |
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
|
+$258M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MON
Monsanto Co
MON
|
+$658M |
| 2 |
COL
Rockwell Collins
COL
|
+$266M |
| 3 |
JWN
Nordstrom
JWN
|
+$264M |
| 4 |
Deutsche Bank
DB
|
+$258M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$250M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 7.19% |
| 2 | Technology | 6.4% |
| 3 | Healthcare | 6.06% |
| 4 | Industrials | 4.94% |
| 5 | Consumer Discretionary | 4.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AKRX
1926
DELISTED
Akorn Inc
AKRX
| $6.68M | ﹤0.01% |
201,285
-66,112
| -25% | -$2.2M |
|
|
AF
1927
DELISTED
Astoria Financial Corporation
AF
| $6.68M | ﹤0.01% |
310,729
+289,082
| +1,335% | +$5.75M |
|
|
SUNS
1928
DELISTED
SLR Senior Investment Corp. Common Stock
SUNS
| $6.68M | ﹤0.01% |
387,586
+75,241
| +24% | +$1.27M |
|
|
CVRR
1929
DELISTED
CVR Refining, LP
CVRR
| $6.67M | ﹤0.01% |
677,660
+411,054
| +154% | +$3.48M |
|
|
CZR
1930
CALL
DELISTED
Caesars Entertainment Corporation
CZR
| $6.67M | ﹤0.01% |
500,000
| – | – |
|
1931
Delek Logistics
DKL
$3.24B
| $6.67M | ﹤0.01% |
213,291
-30,109
| -12% | -$947K |
|
1932
iShares Global Infrastructure ETF
IGF
$11B
| $6.65M | ﹤0.01% |
146,964
-65,695
| -31% | -$2.97M |
|
1933
CALL
IBM
IBM
$208B
| $6.64M | ﹤0.01% |
47,907
-36,924
| -44% | -$5.14M |
|
1934
Pan American Silver
PAAS
$18.2B
| $6.61M | ﹤0.01% |
387,365
-46,902
| -11% | -$809K |
|
|
NUAN
1935
DELISTED
Nuance Communications, Inc.
NUAN
| $6.6M | ﹤0.01% |
484,949
+236,048
| +95% | +$3.37M |
|
|
CEO
1936
DELISTED
CNOOC Limited
CEO
| $6.6M | ﹤0.01% |
50,863
+16,322
| +47% | +$1.89M |
|
|
JHB
1937
DELISTED
Nuveen Corporate Income November 2021 Target Term Fund
JHB
| $6.6M | ﹤0.01% |
654,981
+38,880
| +6% | +$393K |
|
|
CLVS
1938
DELISTED
Clovis Oncology, Inc.
CLVS
| $6.58M | ﹤0.01% |
79,876
+42,987
| +117% | +$3.41M |
|
1939
CALL
Merck
MRK
$322B
| $6.57M | ﹤0.01% |
+107,478
| New | +$6.52M |
|
|
MDC
1940
DELISTED
M.D.C. Holdings, Inc.
MDC
| $6.55M | ﹤0.01% |
248,661
-41,011
| -14% | -$1.08M |
|
1941
PUT
Biogen
BIIB
$30.4B
| $6.54M | ﹤0.01% |
20,900
+16,030
| +329% | +$4.75M |
|
|
BCV
1942
Bancroft Fund
BCV
$132M
| $6.54M | ﹤0.01% |
298,739
-5,215
| -2% | -$114K |
|
1943
Crown Holdings
CCK
$12.8B
| $6.54M | ﹤0.01% |
109,442
+9,231
| +9% | +$547K |
|
|
UMPQ
1944
DELISTED
Umpqua Holdings Corp
UMPQ
| $6.54M | ﹤0.01% |
334,936
+92,090
| +38% | +$1.68M |
|
|
EHT
1945
DELISTED
Eaton Vance 2021 Target Term Trust
EHT
| $6.53M | ﹤0.01% |
642,963
+34,550
| +6% | +$350K |
|
1946
CALL
MBIA
MBI
$265M
| $6.53M | ﹤0.01% |
+750,200
| New | +$7.53M |
|
1947
Oxford Square Capital
OXSQ
$159M
| $6.53M | ﹤0.01% |
952,573
+8,230
| +0.9% | +$55.2K |
|
|
GPP
1948
DELISTED
Green Plains Partners LP
GPP
| $6.52M | ﹤0.01% |
324,201
+1,686
| +0.5% | +$32.3K |
|
1949
Equifax
EFX
$20.4B
| $6.51M | ﹤0.01% |
61,413
+9,183
| +18% | +$1.21M |
|
1950
PUT
Viatris
VTRS
$20.4B
| $6.51M | ﹤0.01% |
207,500
-322,500
| -61% | -$10.9M |
|
Similar funds
UBS Group's Q3 2017 Portfolio in Review
As of Q3 2017, UBS Group held 8,493 positions worth $216B, up 12% from $193B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
UBS Group deployed $15.2B of net new capital in Q3 2017, opening 749 new positions and adding to 3,978 existing holdings. Its largest new stake was Baker Hughes: 613,477 shares worth $22.5M.
By sector, the portfolio is most concentrated in Financials at 7.2% of assets, down from 7.7% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Monsanto Co, an estimated $658M trimmed.
- UBS Group's largest Q3 2017 buy was Baker Hughes: 613,477 shares worth $22.5M.
- UBS Group added most to State Street SPDR S&P 500 ETF Trust in Q3 2017, an estimated $422M increase.
- UBS Group's biggest Q3 2017 reduction was Monsanto Co, cutting an estimated $658M.
- UBS Group fully exited Oneok Partners LP in Q3 2017, selling an estimated $218M.
- UBS Group's ten largest holdings make up 16% of its $216B portfolio in Q3 2017.
- UBS Group opened 749 new positions and closed 707 in Q3 2017.
- UBS Group's portfolio value rose 12% quarter-over-quarter to $216B.
Based on UBS Group's 13F filing for Q3 2017, filed 14 Nov 2017.